Summit Therapeutics (SMMT) stock, a potential rival for Merck (MRK) traded lower as Leerink Partners started its coverage with a Sell-equivalent rating. Read more here.

Performance was more influenced by domestic idiosyncratic factors. The Gulf was the only region that ended down as it was hit by lower oil prices. Morocco led the strong performance across Africa. The ...